Group Finance Business Insights Director - Oncology

At AstraZeneca, we put patients first and strive to meet their unmet needs worldwide. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. If you are swift to action, confident to lead, willing to collaborate, and curious about what science can do, then you’re our kind of person.

AstraZeneca’s Finance function is continuing its transformation journey with the objective of delivering excellence in financial operations and insight.  As this strategy continues to drive the effectiveness and performance of the business, to the benefit of millions of patients worldwide, best in class finance support and leadership becomes ever more important.

What you’ll do

As the Group Insights Director you will play a key role in Group reporting and planning processes, driving central understanding and insight on our Oncology business to inform decision making and target setting on this critical area of the business. This role offers the chance to add real business value through enhanced commercial insight, and the opportunity to build strong and wide-ranging networks within Group and Commercial Finance functions.

We are looking for a candidate with relevant expertise and experience, but more importantly a problem solver, simplifier, integrator, connector and communicator. A change agent who challenges, is curious, works with an agile, positive mindset, and has the ability to think differently and make it happen.

Responsibilities:

The role reports to the Head of Group Insights Finance Director within the broader Group Planning and Business Performance team, and will primarily be responsible for:

• Providing Insight, expertise and analysis to help drive and shape the commercial performance of AstraZeneca

• Being the expert for Oncology within the Group Finance team, acting as the link between the commercial unit and the Group function

• Ensuring that key planning assumptions and drivers of performance are understood, bringing constructive challenge to forecasts, planning assumptions and resource allocation based on credible insights, intelligence & analysis

• Preparing stretched but attainable targets that align to the Enterprise’s strategic and financial objectives

• Developing an understanding of the 10 year Oncology LTP, including a view on pipeline assets and potential

• Proactively identifying, collating and analysing a range of financial and non-financial data to develop a deep understanding of the drivers of performance and key emerging trends impacting our Oncology business

• Developing strong relationships with the embedded functional FP&A contacts in order to refine your understanding whilst bringing constructive challenge to forecasts, assumptions and resource allocation based on credible insights, intelligence & analysis

• Managing a range of other ad-hoc requests in support of the CEO and SET/Board reporting

• Identifying and supporting continuous improvement opportunities in Group Planning and Business Performance processes, performance and reporting

Essential for the role:

• Experience in understanding an Oncology Portfolio in a Pharmaceutical setting

• Experienced and analytical Finance professional with the ability to deliver succinct, high impact briefing material suitable for SET / Board level audiences

• Finance/Business qualification e.g. Qualified ACA/ACCA/CIMA/MBA

• Curious, proactive and delivery focused, comfortable working in a dynamic, challenging environment

• Demonstrated learning agility

• Energetic, resilient and tenacious

• Excellent influencing and communication skills with the confidence to engage senior stakeholders and ability to drive bigger picture thinking

• Good networking and relationship building skills

Desirable for the role:

• Experience of Commercial Finance and/or Group FP&A

• Strong systems skills; advanced Microsoft Excel & PowerPoint, knowledge of Hyperion Planning would also be advantageous

The annual base pay (or hourly rate of compensation) for this position ranges from $178,860.80 - $268,291.20. Base pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills, and experience.  In addition, our positions offer a short-term incentive bonus opportunity and eligibility to participate in our equity-based long-term incentive program (salaried roles). Benefits offered included a qualified retirement program [401(k) plan]; paid vacation and holidays; paid leaves; and, health benefits including medical, prescription drug, dental, and vision coverage in accordance with the terms and conditions of the applicable plans. Additional details of participation in these benefit plans will be provided if an employee receives an offer of employment. If hired, employee will be in an “at-will position” and the Company reserves the right to modify base pay (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance, Company or individual department/team performance, and market factors. 

AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.